100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached 4,6 TrustPilot
logo-home
Exam (elaborations)

Pance Musculoskeletal - Final Test Review(Qns & Ans) - 2025.

Rating
-
Sold
-
Pages
32
Uploaded on
13-06-2025
Written in
2024/2025

Pance Musculoskeletal - Final Test Review(Qns & Ans) - 2025.Pance Musculoskeletal - Final Test Review(Qns & Ans) - 2025.Pance Musculoskeletal - Final Test Review(Qns & Ans) - 2025.

Institution
Pance Certification
Course
Pance Certification











Whoops! We can’t load your doc right now. Try again or contact support.

Written for

Institution
Pance Certification
Course
Pance Certification

Document information

Uploaded on
June 13, 2025
Number of pages
32
Written in
2024/2025
Type
Exam (elaborations)
Contains
Unknown

Subjects

Content preview

Pance Musculoskeletal Exam

Final Test Review

(Questions & Solutions)

2025




1

, 1. Degenerative & Crystal Arthritides (6 questions)

Q1
A 67-year-old woman with longstanding knee OA has failed maximal
NSAIDs, weight loss, and two ultrasound-guided corticosteroid injections
in the past year. Radiographs show Kellgren–Lawrence grade IV changes
with 10° varus deformity. Which intervention offers the greatest
likelihood of durable pain relief and functional restoration?
A. Viscosupplementation series
B. High-tibial valgus osteotomy
C. Medial unicompartmental knee arthroplasty
D. Total knee arthroplasty

ANS: D
Rationale: End-stage tricompartmental OA (grade IV) and
malalignment are best treated by total joint replacement; osteotomy or
partial arthroplasty are suited to isolated unicompartment disease,
viscosupplementation provides only short-term symptom benefit.

---

Q2
A 55-year-old man on hydrochlorothiazide presents with first-MTP
erythema and exquisite pain. Serum urate is 7.4 mg/dL; synovial analysis
shows negatively birefringent needle-shaped crystals. He has stage 3 CKD
(eGFR 48 mL/min). Which oral agent is preferred for long-term urate
lowering?
A. Allopurinol 100 mg daily, titrated to urate < 6 mg/dL
B. Febuxostat 80 mg daily
C. Probenecid 1 g twice daily
D. Colchicine 0.6 mg once daily

ANS: A
2

, Rationale: Xanthine-oxidase inhibition remains first-line in CKD;
allopurinol is safe if dose-escalated slowly. Febuxostat is second-line
given CV concerns; probenecid is contraindicated when CrCl < 50;
colchicine is prophylactic, not urate-lowering.

---

Q3
CPPD arthropathy of the knee demonstrates which characteristic
radiographic finding?
A. Central erosions with overhanging edges
B. Uniform joint-space narrowing sparing the patellofemoral
compartment
C. Chondrocalcinosis of the menisci and articular cartilage
D. Osteophyte formation primarily on the tibial spines

ANS: C
Rationale: CPP crystal deposition produces linear calcification within
hyaline and fibrocartilage—classically seen in menisci or articular
surfaces.

---

Q4
A 60-year-old golfer has glenohumeral OA with intact rotator cuff but <
30° external rotation despite PT. Best surgical option to restore motion
and relieve pain?
A. Arthroscopic debridement with capsular release
B. Hemiarthroplasty
C. Stemless anatomic total shoulder arthroplasty
D. Reverse total shoulder arthroplasty

ANS: C
Rationale: In primary OA with preserved cuff, an anatomic TSA
(including stemless designs) provides superior pain relief and motion vs
3

, hemiarthroplasty; reverse designs are reserved for cuff-deficient arthritis.

---

Q5
Pseudogout is precipitated by which metabolic abnormality most often?
A. Hyperparathyroidism
B. Hypothyroidism
C. Hemochromatosis
D. Hypomagnesemia

ANS: A
Rationale: Hyperparathyroidism, hemochromatosis, hypomagnesemia,
and hypophosphatasia are linked, but primary hyper-PTH is the most
common metabolic association.

---

Q6
A 72-year-old with tricompartmental OA remains symptomatic after
NSAIDs but refuses surgery. Which intra-articular option offers the
longest median duration of relief per meta-analysis?
A. Triamcinolone acetonide
B. High-molecular-weight hyaluronic acid
C. PRP injection
D. Sarilumab (IL-6 inhibitor) investigational use

ANS: C
Rationale: Platelet-rich plasma provides 6–12 months median pain
relief, surpassing steroid (4–6 weeks) and HA (3–6 months); IL-6
inhibitors are not approved.

---

2. Traumatic Fractures & Dislocations (6 questions)
4

Get to know the seller

Seller avatar
Reputation scores are based on the amount of documents a seller has sold for a fee and the reviews they have received for those documents. There are three levels: Bronze, Silver and Gold. The better the reputation, the more your can rely on the quality of the sellers work.
Examiner651 Freelance
View profile
Follow You need to be logged in order to follow users or courses
Sold
19
Member since
3 year
Number of followers
5
Documents
3735
Last sold
3 weeks ago

5.0

2 reviews

5
2
4
0
3
0
2
0
1
0

Recently viewed by you

Why students choose Stuvia

Created by fellow students, verified by reviews

Quality you can trust: written by students who passed their exams and reviewed by others who've used these notes.

Didn't get what you expected? Choose another document

No worries! You can immediately select a different document that better matches what you need.

Pay how you prefer, start learning right away

No subscription, no commitments. Pay the way you're used to via credit card or EFT and download your PDF document instantly.

Student with book image

“Bought, downloaded, and aced it. It really can be that simple.”

Alisha Student

Frequently asked questions